Breaking news Sanofi to acquire Inhibrx-101 for around $2.2B Gennaio 23, 2024 French pharmaceutical company Sanofi S.A. announced in a written statement on Tuesday its decision to acquire Inhibrx-101, an Inhibrx Inc. drug development project, for around $2.2 billion. According…
